IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
0.98
0.00 (0.01%)
At close: May 15, 2025, 1:59 PM
0.01% (1D)
| Bid | 0.96 |
| Market Cap | 64.56M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -95.49M |
| EPS (ttm) | -1.45 |
| PE Ratio (ttm) | -0.68 |
| Forward PE | -0.89 |
| Analyst | Buy |
| Ask | 1.02 |
| Volume | 63,104 |
| Avg. Volume (20D) | 160,773 |
| Open | 0.98 |
| Previous Close | 0.98 |
| Day's Range | 0.93 - 0.98 |
| 52-Week Range | 0.66 - 1.73 |
| Beta | 0.10 |
About IOBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IOBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IOBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+3.22%
IO Biotech share are trading higher after announce...
Unlock content with
Pro Subscription
8 months ago
IO Biotech shares are trading lower after the company announced the IDMC observed no new safety signals in the Phase 3 trial of IO102-IO103. Also, Morgan Stanley maintained an Overweight rating on the stock but lowered its price target from $7 to $4.
